ADC Therapeutics (ADCT) Superinvestor holders
8 of the superinvestors we track hold ADC Therapeutics (ADCT) in their latest 13F filings, $21M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $13M, 0.8% of the portfolio.
In their latest quarter: 1 opened a new position, 6 added.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
Added | 12,326,184 | $13M | 0.8% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Added | 3,649,144 | $4M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 1,006,527 | $1M | 0.0% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Added | 773,414 | $827,553 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 719,320 | $769,672 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 658,125 | $704,193 | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Held | 39,092 | $41,828 | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 36,885 | $39,467 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 8 |
| Q1 2026 | 10 |
| Q4 2025 | 7 |
| Q3 2025 | 7 |
| Q2 2025 | 4 |
| Q1 2025 | 3 |
| Q4 2024 | 3 |
| Q3 2024 | 4 |
Questions about ADC Therapeutics
Which superinvestors own ADC Therapeutics?
8 of the superinvestors we track hold ADC Therapeutics (ADCT) in their latest 13F filings, $21M in total. Wilmot Harkey, Steve Cohen, Acadian, Two Sigma, David Shaw, Cliff Asness.
Who is the largest superinvestor holder of ADCT?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $13M, 0.8% of the portfolio.
From ADC Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.